Latest News

As the Canadian market celebrates the third anniversary of its bull run, investors are assessing where opportunities might lie amidst easing inflation and shifting trade dynamics. Penny stocks, while often seen as a relic from past eras, continue to offer intriguing prospects for those seeking affordability and growth potential in smaller or newer companies. In this article, we explore three penny stocks that stand out for their financial resilience and potential to perform well in the...

When we invest, we're generally looking for stocks that outperform the market average. And the truth is, you can make...

Livestock Improvement Corporation Limited's ( NZSE:LIC ) price-to-earnings (or "P/E") ratio of 5x might make it look...

While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...

Rakus (TSE:3923) just shared its consolidated sales figures for September of Fiscal Year 2026, coming in at JPY 4,975 million. These monthly results provide investors with a timely glimpse into how the company’s business is trending. See our latest analysis for Rakus. Rakus shares have delivered a robust 44.98% year-to-date price return, reflecting strong momentum as investors respond to its consistent operational growth and recent sales update. Over the last year, the total shareholder...

Sprinklr (CXM) has appointed Karthik Suri as its new Chief Product and Corporate Strategy Officer, effective immediately. This move underscores the company's focus on accelerating product vision and overall corporate strategy. See our latest analysis for Sprinklr. Sprinklr shares have seen some renewed investor interest since the news of Karthik Suri stepping in, with the 1-week and 1-day share price returns both showing modest gains. However, momentum has yet to reverse this year's overall...

If you're staring at your portfolio and wondering what’s next for First Horizon, you’re not alone. The stock has been on a bit of a rollercoaster lately, and whether you’re thinking of getting in, doubling down, or hitting the brakes, understanding what’s behind the moves is key. Over the past week, First Horizon nudged up by 2.2%, hinting at a touch of renewed optimism in the short term. Of course, zooming out, the picture gets more interesting: over the last month, shares dropped 8.1%, but...

Nuvalent (NUVL) just shared preliminary results from its ALKOVE-1 Phase 1/2 clinical trial, focusing on neladalkib in advanced ALK-positive solid tumors, excluding non-small cell lung cancer. These findings were highlighted in advance of a presentation at ESMO 2025. See our latest analysis for Nuvalent. Nuvalent’s latest trial results seem to have ignited fresh optimism, with momentum clearly building. The 1-month share price return stands at 20.05%, and its total shareholder return over...

Socionext (TSE:6526) has unveiled its new Flexlets platform, an advanced series of configurable chiplets aimed at tackling industry-wide challenges in scalability and integration for next-generation semiconductor devices. This launch marks a move toward greater design flexibility and accelerated innovation within the chip industry. See our latest analysis for Socionext. Socionext’s push into customizable chiplets comes as momentum around the stock continues to build, with a 12.6% share price...

On October 20, 2025, Anthropic and 10x Genomics announced a collaboration to integrate 10x's advanced analysis tools into Claude for Life Sciences, allowing researchers to interact with single cell and spatial biology data using natural language via the Model Context Protocol (MCP). This advancement reduces the technical barrier for life sciences researchers, potentially broadening adoption of 10x's technologies across institutions and accelerating data-driven scientific discovery. We'll now...

Baidu (NasdaqGS:BIDU) is in the spotlight this week, following its announcement of Baidu World 2025 and a new partnership to deploy autonomous vehicles in Switzerland. Investors are watching how these developments could shape Baidu’s future growth story. See our latest analysis for Baidu. Baidu's recent rally, including a 4.81% gain in share price over just the past day and an impressive 48% share price return over the last 90 days, has caught the market’s eye. This momentum comes as the...

Perpetua Resources recently announced it raised US$255 million through equity investments from Agnico Eagle Mines and JPMorgan Chase to advance the Stibnite Gold Project in Idaho, with Agnico Eagle committing US$180 million for a 6.5% stake and additional warrants. This move strengthens Agnico Eagle Mines' position in domestic gold and antimony production while reinforcing market confidence in its growth strategy and low-cost operations. We'll explore how Agnico Eagle's major investment in a...

Several research firms kicked off or updated their coverage of MARA Holdings (MARA) following its acquisition of a major stake in Exaion and its ongoing strong mining output. Investors are watching closely as the company cements its place in the Bitcoin mining landscape. See our latest analysis for MARA Holdings. MARA Holdings has had a rollercoaster year, with recent analyst coverage and industry shake-ups adding fuel to the narrative. Despite the sector's short-term volatility, MARA's...

Acadian Asset Management (AAMI) has caught investor attention as Weiss Ratings moved its rating from buy to hold, just days before the company’s upcoming earnings announcement. Several analysts have also revised their outlooks, highlighting changing sentiment around the stock. See our latest analysis for Acadian Asset Management. Acadian Asset Management’s share price has surged an impressive 92% year-to-date, reflecting growing optimism even as analyst sentiment shows signs of cooling. The...

In recent weeks, Baxter International faced renewed legal pressures as multiple law firms issued notices about securities class action lawsuits alleging the company misrepresented product safety and risks related to its Novum infusion pump, with claims of patient harm and misleading disclosures. These legal developments, compounded by the resignation of the company's Chief Operating Officer and an imminent leadership transition, have intensified investor concerns around operational,...

Macnica Holdings (TSE:3132) posted an annualized earnings growth rate of 16.5% over the past five years, with current earnings forecasts calling for a robust 29.98% per year increase. Revenue is projected to expand by 7.5% annually, well above the Japanese market’s 4.5% growth pace. While the company’s net profit margin has slipped to 1.9% from 3.7% last year, investors are watching a share price of ¥2,173 against an estimated fair value of ¥5,792.07, and noting a premium valuation with a...

Calm Health recently announced a partnership with LifeStance Health Group, making it possible for Calm Health app users in need of higher-acuity mental health care to be referred directly to LifeStance’s network for therapy, psychiatry, and psychological services, either in-person or virtually. This integration leverages Calm Health’s screening and personalized care pathways to potentially broaden patient access to LifeStance’s offerings and streamline users’ connection to appropriate levels...

AtriCure (ATRC) just kicked off a major clinical milestone by enrolling the first patient in its BoxX-NoAF trial. This FDA-approved study aims to test new device strategies for reducing atrial fibrillation after heart surgery. See our latest analysis for AtriCure. Momentum has been quietly building for AtriCure, with its 90-day share price return of 14.9% and year-to-date gain nearing 20%. Recent news of its groundbreaking BoxX-NoAF trial has helped maintain positive sentiment. Although the...

Expand Energy (EXE) drew investor attention this week after announcing it will report third-quarter earnings after market close on October 28. This comes as the company pursues ambitious plans to nearly double its U.S. LNG export capacity by 2030. The strategy aims to align with rapidly growing data center power needs and ongoing shifts in energy demand. See our latest analysis for Expand Energy. Shares of Expand Energy have built steady momentum this year, with a 25.8% total return over the...

If you’re watching Rayonier lately and wondering whether now is the right time to buy, hold, or steer clear, you’re not alone. The stock closed most recently at $23.33, catching the eye of many investors after a choppy ride. Over the last week, shares are down 5.0%, capping off a one-month slide of nearly 11.8%. Looking further back, the story is mixed: a painful 12.9% drop on the year, but the five-year performance shows a solid 23.5% gain, which can’t be ignored. This tug-of-war between...

Brown & Brown, Inc. recently reported third-quarter earnings that exceeded analyst expectations, with revenue rising to US$1.61 billion and a 10% increase in its quarterly dividend, while also expanding its share buyback authorization by US$1.25 billion. An interesting highlight was the company's addition of over 5,000 new teammates in the quarter, reflecting ongoing acquisition activity fueling both growth and operational scale. To understand how Brown & Brown’s earnings beat and capital...

Illinois Tool Works Inc. recently reported its third-quarter 2025 results, revealing revenue growth to US$4.06 billion and earnings per share of US$2.81, while also announcing the completion of a US$2.64 billion share repurchase under a previously authorized buyback program. A key insight is that, despite achieving record operating margins and raising its dividend for the 62nd consecutive year, the company’s cautious full-year outlook reflected ongoing challenges in demand and supply chain...

Centuri Holdings recently named Ryan Palazzo as President of its U.S. Gas segment, a division that generates about half of the company’s overall revenue. Investors are watching how his industry experience could influence Centuri’s next phase. See our latest analysis for Centuri Holdings. Centuri Holdings has seen its share price climb 7.1% year-to-date, while the total shareholder return over the past twelve months is a solid 12%. The momentum is encouraging, especially as news of Ryan...

Keurig Dr Pepper (KDP) posted average annual earnings growth of 2.8% over the past five years. However, the latest year saw earnings decline and net profit margins compress from 14.5% to 9.7%. Looking forward, revenue is forecast to grow by 3.7% per year, while earnings growth is expected to pick up to 8.6% annually. These numbers still trail higher-growth peers. A significant $787 million one-off loss in the last twelve months has weighed on reported earnings and margin quality. Investors...